研究发现,在子宫内接触偏头痛药物的儿童中,自闭症或ADHD的风险没有增加。 Study finds no increased risk of autism or ADHD in children exposed to migraine drugs in utero.

最近对神经学的一项研究发现,在怀孕期间服用偏头痛药物(称为三联苯)的母亲所生儿童患自闭症或ADDHD等神经发育紊乱的风险没有增加。 A recent study in Neurology found no increased risk of neurodevelopmental disorders such as autism or ADHD in children born to mothers who took migraine drugs called triptans during pregnancy. 这项研究追踪了挪威儿童长达14年, 涉及超过26,000名怀孕妇女, 并没有发现产前接触酸盐与神经发育问题之间存在联系. The research, which tracked Norwegian children for up to 14 years, involved over 26,000 pregnancies and found no link between prenatal exposure to triptans and neurodevelopmental issues. 这为患有偏头痛的孕妇提供了保证。 This provides reassurance for pregnant women with migraines.